Search | IOVS | ARVO Journals

View

Showing 1 – 8 of 8

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Adaptive optics phenotypes of intermediate age-related macular degeneration

Ahmed M Hagag; Sophie Riedl; Toby Prevost; Lars Fritsche; Daniel Rueckert; Hendrik P Scholl; Ursula Schmidt-Erfurth; Sobha Sivaprasad; Andrew J Lotery

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2322. doi:

ARVO Annual Meeting Abstract June 2022

Risk factors for progression of intermediate age-related macular degeneration: A systematic review and meta-analysis

Andrew J Lotery; Ahmed M Hagag; Rebecca Kaye; Sophie Riedl; Vy Hoang; Philipp Anders; Christian Appenzeller-Herzog; Ursula Schmidt-Erfurth; Hendrik P Scholl; Toby Prevost; Lars Fritsche; Daniel Rueckert; Sobha Sivaprasad; Ghislaine Traber; Beth Stuart

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2530 – A0099. doi:

ARVO Annual Meeting Abstract June 2022

Self-supervised pretraining enables deep learning-based classification of AMD with fewer annotations

Robbie Holland; Martin Joseph Menten; Oliver Leingang; Hrvoje Bogunovic; Ahmed M Hagag; Rebecca Kaye; Sophie Riedl; Ghislaine Traber; Lars Fritsche; Toby Prevost; Hendrik P Scholl; Ursula Schmidt-Erfurth; Sobha Sivaprasad; Daniel Rueckert; Andrew J Lotery

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3004 – F0274. doi:

ARVO Annual Meeting Abstract June 2022

Automated deep learning-based AMD stage detection in real-world OCT datasets

Oliver Leingang; Hrvoje Bogunovic; Sophie Riedl; Arunava Chakravarty; Martin Joseph Menten; Robbie Holland; Ghislaine L Traber; Lars Fritsche; Toby Prevost; Hendrik P Scholl; Daniel Rueckert; Sobha Sivaprasad; Andrew J Lotery; Ursula Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2106 – F0095. doi:

ARVO Annual Meeting Abstract June 2022

Automated detection of morphologic changes on SD-OCT leading toward outer retinal atrophy in intermediate age-related macular degeneration in the prospective PINNACLE trial

Sophie Riedl; Wolf-Dieter Vogl; Oliver Leingang; Hrvoje Bogunovic; Lars Fritsche; Toby Prevost; Daniel Rueckert; Hendrik P Scholl; Sobha Sivaprasad; Andrew J Lotery; Ursula Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2319. doi:

ARVO Annual Meeting Abstract June 2022

Discovery of imaging biomarkers for healthy aging and age-related macular degeneration using counterfactual generative adversarial networks

Martin Joseph Menten; Oliver Leingang; Hrvoje Bogunovic; Robbie Holland; Ahmed M Hagag; Rebecca Kaye; Sophie Riedl; Ghislaine Traber; Lars Fritsche; Toby Prevost; Hendrik P Scholl; Ursula Schmidt-Erfurth; Sobha Sivaprasad; Daniel Rueckert; Andrew J Lotery

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3855. doi:

Retina August 2018

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

PDF

Luke Nicholson; Roxanne Crosby-Nwaobi; Joana C. Vasconcelos; A. Toby Prevost; Jayashree Ramu; Amy Riddell; James W. Bainbridge; Philip G. Hykin; Sobha Sivaprasad
TAGS: aflibercept, panretinal photocoagulation, proliferative diabetic retinopathy, eye, oximetry
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):4277-4284. doi: https://doi.org/10.1167/iovs.17-23509

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

A Multicentre Double-masked Randomised Controlled Non-Inferiority Trial comparing clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion [LEAVO]: Baseline patient sociodemographic and ocular characteristics.

Philip G Hykin; Joana Vasconcelas; Toby Prevost; Sobha Sivaprasad; Barry Hounsome; Usha Chakravarthy; Simon Harding; Andrew Lotery; Yit C. Yang; Piyali Sen; Jayashree Ramu; Luke Nicholson; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2569. doi:

Advertisement